scholarly journals Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease

Pituitary ◽  
2015 ◽  
Vol 19 (2) ◽  
pp. 138-148 ◽  
Author(s):  
Maria Fleseriu ◽  
Rosario Pivonello ◽  
Jacques Young ◽  
Amir H. Hamrahian ◽  
Mark E. Molitch ◽  
...  
Pituitary ◽  
2013 ◽  
Vol 17 (4) ◽  
pp. 320-326 ◽  
Author(s):  
M. Boscaro ◽  
J. Bertherat ◽  
J. Findling ◽  
M. Fleseriu ◽  
A. B. Atkinson ◽  
...  

Pancreatology ◽  
2013 ◽  
Vol 13 (3) ◽  
pp. S88-S89
Author(s):  
Nelide De Lio ◽  
Enrico Vasile ◽  
Mario Antonio Belluomini ◽  
Francesca Costa ◽  
Carla Cappelli ◽  
...  

1999 ◽  
Vol 10 (12) ◽  
pp. 1467-1474 ◽  
Author(s):  
S. Rodenhuis ◽  
R. de Wit ◽  
P.H.M. de Mulder ◽  
H.J. Keizer ◽  
D.T. Sleijfer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document